title: Psychopharmacological treatment of mood and anxiety disorders during pregnancy.
abstract: Many women with psychiatric disorders want to become mothers and only a minority seek advise prior to becoming pregnant. In those women, in whom pregnancy can be planned, the decision, if a medication is required for stabilisation and which one to choose if this is the case, is easier to make than in women in whom pregnancy occurs unplanned. The physician has to weigh the risk that a relapse of the psychiatric disorder during pregnancy poses to the foetus against the reproductive risk of psychotropic drugs. This presentation is intended to assist in understanding the general principles of pharmacotherapy during pregnancy as well as the morphological, perinatal and neurobehavioural toxicity of antidepressants, antipsychotics, benzodiazepines and mood stabilisers.
authors.affiliation: Zentrum für Seelische Frauengesundheit, Vivantes Humboldt-Klinikum, Berlin, Germany. stephanie.krueger@vivantes.de
authors.forename: Stephanie
authors.initials: S
authors.lastname: Krüger
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D001008:Anxiety Disorders / Q000188:drug therapy*; D005260:Female; D005333:Fetus / Q000187:drug effects*; D006801:Humans; D019964:Mood Disorders / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011619:Psychotropic Drugs / Q000009:adverse effects*
chemical_list: D011619:Psychotropic Drugs